Answers are grounded in this paper and cite their sources.
Intercellular mitochondrial transfer is increasingly recognized as a form of cellular communication relevant to central nervous system (CNS) injury. Intact, respiration-competent mitochondria are thought to restore metabolism, reduce oxidative stress, and limit neuroinflammation; damaged or fragmented cargo, by contrast, is non-functional and may instead act as a pro-inflammatory danger signal. This review organizes the field around the neurovascular unit (NVU), focusing on the triggers, directionality, and routes of mitochondrial transfer and the forms of its cargo, as well as the degradative fates—including transmitophagy—that determine whether transferred mitochondria are ultimately integrated or cleared. Progress in this field now depends less on proving whether transfer occurs than on clarifying how it occurs and how reliably and reproducibly it confers benefit. Accordingly, we examine key methodological issues underlying current interpretations of the proposed neuroprotective mechanisms and their limitations—in particular, susceptibility to dye-labeling artifacts and the scarcity of functional validation. Finally, we summarize progress in preclinical research on mitochondrial transplantation and the few clinical studies to date, comparing donor-source selection, delivery routes, dose estimation, and bioengineering strategies, and safety considerations, with the aim of informing future clinical translation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: